Skip to main content

Advertisement

Fig. 4 | Fluids and Barriers of the CNS

Fig. 4

From: Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab

Fig. 4

Relationship between rCBV measurements and time interval to post-treatment MRI. Top hot spot rCBV measurements in ROIpost (filled) and ROIpre (open); y axis is % rCBV reduction, a negative value indicates rCBV increase. Bottom mean rCBV over the entire enhancing lesion. No significant relationships of rCBV with post-treatment MRI time intervals were found (all P > 0.1)

Back to article page